|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,054.32 USD | +2.61% |
|
+5.87% | +36.80% |
| 04:36pm | Eli Lilly's GLP-1 Franchise to Drive 26% Revenue Growth in 2026, BofA Securities Says | MT |
| 04:05pm | US FDA grants priority voucher to J&J's blood cancer treatment | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 920B | |||||
| 510B | |||||
| 395B | |||||
| 340B | |||||
| 278B | |||||
| 254B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition